NSE › Healthcare

Wockhardt Limited (WOCKPHARMA)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹2,028.40+3.51%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
₹965 cr
Revenue YoY
+26.0%
Net profit
₹166 cr
Profit YoY
+764.0%
EPS
₹31.20
EPS estimate
₹4.50
Net margin
17.2%

EPS came in at 31.20 against a street estimate of 4.50 — a beat of 593.3%.

Key statistics

Market cap
₹31,811 cr
P/E
149.1
Forward P/E
3.8
P/B
6.45
Book value
₹304.44
EPS (TTM)
₹13.13
52-week high
₹2,422.30
52-week low
₹1,086.70
50-day MA
₹1,912.32
200-day MA
₹1,507.62
Beta
0.93

Analyst view

with an average price target of ₹450.00.

Shareholding

Promoters
51.02%
Institutions
14.79%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Wockhardt Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedCipla LimitedZydus Lifesciences LimitedLupin LimitedMax Healthcare Institute LimitedMankind Pharma LtdLaurus Labs LimitedLenskart Solutions LtdDr. Reddy's Laboratories Limited

Data updated 2026-08-05.